Valuation: genOway

Market Cap 1.73Cr 1.93Cr 1.6Cr 1.45Cr 2.75Cr 181.22Cr 2.82Cr 19Cr 7.62Cr 97Cr 7.25Cr 7.1Cr 306.94Cr P/E 2024 *
-
P/E 2025 -
Enterprise Value 2.41Cr 2.68Cr 2.22Cr 2.01Cr 3.81Cr 251.46Cr 3.92Cr 27Cr 11Cr 134.72Cr 10Cr 9.85Cr 425.9Cr EV / Sales 2024
1.36x
EV / Sales 2025 1.22x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day+5.32%
1 week+3.39%
Current month-4.35%
1 month-10.81%
3 months-20.80%
6 months-21.43%
Current year-26.94%
1 week 1.81
Extreme 1.81
2.02
1 month 1.81
Extreme 1.81
2.26
Current year 1.81
Extreme 1.81
2.79
1 year 1.81
Extreme 1.81
2.88
3 years 1.81
Extreme 1.81
4.91
5 years 1.81
Extreme 1.81
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
20/01/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
+5.32%+3.39%-15.74%-51.94% 1.93Cr
+0.01%+11.10%+60.83%+70.43% 6.83TCr
+0.72%+6.77%+14.11%+89.13% 6.03TCr
+0.09%0.00%+19.68%+97.14% 5.59TCr
+1.60%+19.44%+28.80%+112.95% 4.84TCr
-1.32%+4.78%+29.15%+40.40% 4.53TCr
-3.54%-0.60%+207.76%+879.50% 4.18TCr
-3.33%+6.90%+22.78%+48.07% 3.45TCr
-1.26%-1.20%+84.21%+56.55% 3.38TCr
-1.49%+1.16%+47.05%+0.16% 2.6TCr
Average -0.33%+3.89%+49.86%+134.24% 4TCr
Weighted average by Cap. -0.68%+5.25%+53.96%+152.59%

Financials

2024 2025
Net sales 2.58Cr 2.88Cr 2.38Cr 2.16Cr 4.09Cr 270.18Cr 4.21Cr 29Cr 11Cr 144.75Cr 11Cr 11Cr 457.61Cr 2.6Cr 2.9Cr 2.4Cr 2.18Cr 4.12Cr 272.14Cr 4.24Cr 29Cr 11Cr 145.8Cr 11Cr 11Cr 460.92Cr
Net income 18.31L 20.41L 16.87L 15.32L 29L 19Cr 29.81L 2.02Cr 80.49L 10Cr 76.61L 74.99L 32Cr 9L 10.35L 9L 8L 14.7L 9.7Cr 15.11L 1.02Cr 40.79L 5.2Cr 38.82L 38L 16Cr
Net Debt 6L 7L 6L 5L 10L 6.51Cr 10.14L 68.74L 27.39L 3.49Cr 26.07L 25.52L 11Cr 67.18L 74.91L 61.91L 56.23L 1.06Cr 70Cr 1.09Cr 7.41Cr 2.95Cr 38Cr 2.81Cr 2.75Cr 118.96Cr
Projected Income Statement - Annual - genOway
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
163
Date Price Change Volume
11/26/11 €1.980 +5.32% 2,351
10/26/10 €1.880 -1.05% 19,604
09/26/09 €1.900 -3.80% 20,183
06/26/06 €1.975 -1.00% 3,699
05/26/05 €1.995 +4.18% 8,820
  1. Stock Market
  2. Stocks
  3. ALGEN Stock